Delivery Order SPE2DB24D2205-SPE2DB25FECFS
Award Date 5/12/25
Potential Completion Date 5/13/25
Potential Value $24K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $9,725.21 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens, a GLP-1 receptor agonist medication used in diabetes and weight management treatment. This firm fixed-price, competitively awarded delivery order is set to be completed by August 7, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pens, a GLP-1 receptor agonist medication used for weight management. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $3,050.40 and an ultimate completion date of August 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $12,879.01 for Zepbound 5 mg/0.5 mL pen injectors, a GLP-1 receptor agonist medication used for weight management. This firm fixed-price delivery order, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The contract utilizes no set-aside designation, indicating open...
- The Defense Logistics Agency awarded a $11,086.64 delivery order to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 mL pen injectors (0.5 mL), a GLP-1 receptor agonist medication used for weight management. This firm fixed price, non-set-aside contract was awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $7,218.52 delivery order to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 ml pen injections (0.5 ml), a GLP-1 receptor agonist medication used for weight management. The contract, executed on August 26, 2025, with completion targeted for August 27, 2025, utilizes firm fixed-price pricing under a non-set-aside competitive procurement. Performance will be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a $42,553.88 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens, a GLP-1 receptor agonist medication used for weight management and diabetes treatment. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 10, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside...
- The Defense Logistics Agency awarded a $1,525.20 delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 ml pen (0.5 ml), a GLP-1 receptor agonist medication used for weight management. This firm fixed-price, competitively awarded delivery order was issued on September 3, 2025, with an ultimate completion date of September 4, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,234.96 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen (0.5ml), a GLP-1 receptor agonist medication used for weight management. The contract is a firm fixed-price delivery order with no set-aside designation, awarded on August 26, 2025, with an ultimate completion date of August 27, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies on August 14, 2025, with a ceiling value of $1,143.87. This non-set-aside, competitively awarded contract calls for the delivery of Zepbound 15 mg/0.5 mL pen injections, a GLP-1 receptor agonist medication used in weight management and diabetes treatment. The order is structured as a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and will be...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,988.33 on June 2, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pens with an ultimate completion date of June 3, 2025. This firm fixed-price, competitively awarded contract involves no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle...